伊人久久大香线蕉AV影院,情侣国产一二三区视频观看,香蕉丝瓜榴莲在线观看√天堂资源中文官网,日韩精品无码观看视频免费,亚洲伊人成无码综合网欧美亚洲综合在线一区,国产午夜精品视频一区二区三区,亚洲毛片在线日韩无码大乱交,国产精品国产三级欧美二区

Dec 19, 2022

Mabwell Was Ranked in the "List of New and Innovative Chinese Pharmaceutical Forces"

?

Dec 01, 2022

Mabwell Published Pre-clinical Study Results of CD47/PD-L1 Bi-specific Antibody 6MW3211

?

Nov 23, 2022

Dr. Liu Datao, Co-founder and CEO of Mabwell, was Honored as “Sci-Tech Innovation Board Leaders，2022”

?

Nov 22, 2022

Mabwell and Junshi Announce the Approval of Five Indications for Adalimumab

?

Nov 21, 2022

Mabwell Announces the U.S. FDA approval of 9MW3011 (FIC) for IND

?

Nov 18, 2022

Dr. Liu Datao, CEO of Mabwell, Was Invited to Participate in the Live Interview of "International Biopharma Industry Week Shanghai 2022" by Yicai

?

Nov 16, 2022

Mabwell Awarded "Zhangjiang Life Science Industry New Prominent · 2022"

?

Nov 11, 2022

Mabwell Ranked the List of Top 20 Most Influential Antibody Pharmaceutical Companies in China 2022

?

Oct 21, 2022

Wu Zhiyuan, Director of Development Research Center of People's Government of Pudong New Area, and His Entourage Visited Mabwell for Research and Guidance

?

Oct 19, 2022

First in Class! Mabwell's Clinical Trial Application for 9MW3011 Injection - An Innovative Drug Accepted by NMPA

?